Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
DFPS93
|
|||
Drug Name |
Pravibismane
|
|||
Synonyms |
UNII-G3T79NDD38; 1,2-(BiS(1,3-dithia-2-bismolane)thio)ethane; 175880-68-9; G3T79NDD38; 2,2'-[ethane-1,2-diylbis(sulfanediyl)]bis(1,3,2-dithiabismolane); Q27278698
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Respiratory tract infection [ICD-11: CA45; ICD-10: J13, J15] | Phase 2 | [1] | |
Company |
Microbion Biosciences
|
|||
Structure |
Download2D MOL
|
|||
Formula |
C6H12Bi2S6
|
|||
Canonical SMILES |
C1CS[Bi](S1)SCCS[Bi]2SCCS2
|
|||
InChI |
1S/3C2H6S2.2Bi/c3*3-1-2-4;;/h3*3-4H,1-2H2;;/q;;;2*+3/p-6
|
|||
InChIKey |
GUTNLKRPYCTIHX-UHFFFAOYSA-H
|
|||
CAS Number |
CAS 175880-68-9
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT02436876) Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.